OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 92 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 13.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $740,000 | +49.5% | 84,110 | +1.9% | 0.04% | +52.0% |
| Q4 2017 | $495,000 | +33.8% | 82,511 | +2.7% | 0.02% | +25.0% |
| Q3 2017 | $370,000 | -31.6% | 80,380 | -4.9% | 0.02% | -35.5% |
| Q2 2017 | $541,000 | +33.9% | 84,518 | +0.5% | 0.03% | +29.2% |
| Q1 2017 | $404,000 | -12.6% | 84,135 | -10.6% | 0.02% | -17.2% |
| Q4 2016 | $462,000 | -22.2% | 94,150 | -21.4% | 0.03% | -23.7% |
| Q3 2016 | $594,000 | -5.6% | 119,842 | -3.1% | 0.04% | -11.6% |
| Q2 2016 | $629,000 | -7.2% | 123,617 | +4.2% | 0.04% | -12.2% |
| Q1 2016 | $678,000 | -44.8% | 118,673 | +0.3% | 0.05% | -47.3% |
| Q4 2015 | $1,228,000 | +967.8% | 118,284 | +428.4% | 0.09% | +675.0% |
| Q3 2015 | $115,000 | -92.3% | 22,386 | -70.7% | 0.01% | -92.2% |
| Q2 2015 | $1,488,000 | +56.0% | 76,469 | +40.9% | 0.15% | +45.7% |
| Q1 2015 | $954,000 | +116.8% | 54,284 | +97.2% | 0.10% | +84.2% |
| Q4 2014 | $440,000 | +230.8% | 27,529 | +159.9% | 0.06% | +147.8% |
| Q3 2014 | $133,000 | – | 10,591 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,240,709 | $23,259,000 | 3.12% |
| PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $361,000 | 0.25% |
| Freedom Investment Management, Inc. | 118,284 | $1,228,000 | 0.09% |
| Spark Investment Management LLC | 62,800 | $651,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 98,901 | $1,027,000 | 0.05% |
| Baker Brothers Advisors | 499,193 | $5,182,000 | 0.04% |
| KILLEN GROUP INC | 31,000 | $322,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 127,263 | $1,321,000 | 0.02% |
| A.R.T. Advisors, LLC | 27,049 | $280,000 | 0.01% |
| QS Investors, LLC | 132,027 | $1,370,000 | 0.01% |